{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:21:11Z","timestamp":1777958471878,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd011965","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000}}],"reference-count":79,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011965.pub2","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T14:58:49Z","timestamp":1486479529000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Topical treatments for blepharokeratoconjunctivitis in children"],"prefix":"10.1002","volume":"2017","author":[{"given":"Michael","family":"O'Gallagher","sequence":"first","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust; 162 City Road London UK EC1V 2PD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[{"name":"Kings College London; Department of Primary Care & Public Health Sciences; 4th Floor, Addison House Guy's Campus London UK SE1 1UL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Hingorani","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust; 162 City Road London UK EC1V 2PD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Larkin","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust; Cornea and External Disease Department; 162 City Road London UK EC1V 2PD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Tuft","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust; Cornea and External Disease Department; 162 City Road London UK EC1V 2PD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annegret","family":"Dahlmann-Noor","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology; 162 City Road London UK EC1V 2PD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD011965.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/11596320-000000000-00000","article-title":"Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects","volume":"14","author":"Comstock","year":"2012","journal-title":"Paediatric Drugs"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/112067219400400102","article-title":"Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis","volume":"4","author":"Bloom","year":"1994","journal-title":"European Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1185\/03007995.2012.659723","article-title":"A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%\/tobramycin 0.3% with dexamethasone 0.1%\/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis","volume":"28","author":"Chen","year":"2012","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2147\/OPTH.S52474","article-title":"A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitis","volume":"7","author":"Hosseini","year":"2013","journal-title":"Clinical Ophthalmology"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0005|cit5","first-page":"192","article-title":"A double-blind, comparative clinical trial of a new steroid, anti-infective ophthalmic ointment for chronic staphylococcal blepharoconjunctivitis","volume":"1","author":"Shulman","year":"1982","journal-title":"Ocular Therapy and Surgery"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1185\/030079908X253898","article-title":"Comparison of the safety and efficacy of loteprednol 0.5%\/tobramycin 0.3% with dexamethasone 0.1%\/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis","volume":"24","author":"White","year":"2008","journal-title":"Current Medical Research and Opinion"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4158\/EP.9.6.526","article-title":"Cushing's syndrome caused by unsupervised use of ocular glucocorticoids","volume":"9","author":"Afandi","year":"2003","journal-title":"Endocrine Practice"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1167\/iovs.10-6997h","article-title":"The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee","volume":"52","author":"Asbell","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD011965.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00347-009-1954-9","article-title":"Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors","volume":"106","author":"Auw-H\u00e4drich","year":"2009","journal-title":"Ophthalmologe"},{"issue":"9","key":"10.1002\/14651858.CD011965.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/ICO.0000000000000200","article-title":"Sub-tenon triamcinolone acetonide injections for topical medication intolerance in chronic blepharokeratoconjunctivitis","volume":"33","author":"Bondalapati","year":"2014","journal-title":"Cornea"},{"issue":"7","key":"10.1002\/14651858.CD011965.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3928\/01913913-20100118-01","article-title":"Augmentin duo\u2122 in the treatment of childhood blepharokeratoconjunctivitis","volume":"47","author":"Cehajic-Kapetanovic","year":"2010","journal-title":"Journal of Pediatric Ophthalmology and Strabismus"},{"issue":"5","key":"10.1002\/14651858.CD011965.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Survey of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.eye.6701956","article-title":"Exogenous Cushing's syndrome and topical ocular steroids","volume":"20","author":"Chiang","year":"2006","journal-title":"Eye"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaapos.2012.10.015","article-title":"Oral azithromycin combined with topical anti-inflammatory agents in the treatment of blepharokeratoconjunctivitis in children","volume":"17","author":"Choi","year":"2013","journal-title":"Journal of AAPOS"},{"issue":"5","key":"10.1002\/14651858.CD011965.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14656561003667532","article-title":"Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens","volume":"11","author":"Comstock","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"789623","DOI":"10.1155\/2012\/789623","article-title":"Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate","volume":"2012","author":"Comstock","year":"2012","journal-title":"International Journal of Inflammation"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0018|cit18","unstructured":"Deeks JJ Higgins JP Altman DG editor(s) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ajo.2006.09.058","article-title":"Long-term visual outcome of childhood blepharokeratoconjunctivitis","volume":"143","author":"Doan","year":"2007","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1869-5760-3-38","article-title":"Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis","volume":"3","author":"Doan","year":"2013","journal-title":"Journal of Ophthalmic Inflammation and Infection"},{"issue":"12","key":"10.1002\/14651858.CD011965.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1167\/iovs.11-8027","article-title":"Rasch analysis of the Ocular Surface Disease Index (OSDI)","volume":"52","author":"Dougherty","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD011965.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/ICO.0000000000000419","article-title":"Corneal fine needle diathermy with adjuvant bevacizumab to treat corneal neovascularization in children","volume":"34","author":"Elbaz","year":"2015","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000060709","article-title":"Monitoring of activity and progression in cicatrising conjunctivitis","volume":"28","author":"Elder","year":"1997","journal-title":"Developments in Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00003226-199507000-00006","article-title":"An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics","volume":"14","author":"Everett","year":"1995","journal-title":"Cornea"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3928\/0191-3913-20010701-06","article-title":"Diagnosis and management of chronic blepharokeratoconjunctivitis in children","volume":"38","author":"Farpour","year":"2001","journal-title":"Journal of Pediatric Ophthalmology and Strabismus"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1542-0124(12)70139-8","article-title":"Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading","volume":"1","author":"Foulks","year":"2003","journal-title":"Ocular Surface"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0028|cit28","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2014"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaapos.2010.09.013","article-title":"Clinical spectrum of pediatric blepharokeratoconjunctivitis","volume":"14","author":"Gupta","year":"2010","journal-title":"Journal of AAPOS"},{"issue":"7","key":"10.1002\/14651858.CD011965.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bjophthalmol-2011-300771","article-title":"Childhood blepharokeratoconjunctivitis: characterising a severe phenotype in white adolescents","volume":"96","author":"Hamada","year":"2012","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jaapos.2012.12.057","article-title":"The activity and damage of blepharokeratoconjunctivitis in children","volume":"17","author":"Hamada","year":"2013","journal-title":"Journal of AAPOS"},{"issue":"12","key":"10.1002\/14651858.CD011965.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archopht.123.12.1667","article-title":"Blepharokeratoconjunctivitis in children","volume":"123","author":"Hammersmith","year":"2005","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/ICU.0000000000000167","article-title":"Blepharokeratoconjunctivitis in children","volume":"26","author":"Hammersmith","year":"2015","journal-title":"Current Opinion in Ophthalmology"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0034|cit34","unstructured":"Higgins JP Deeks JJ editor(s) Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0035|cit35","unstructured":"Higgins JP Altman DG editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0036|cit36","first-page":"33","article-title":"Topical cyclosporin as an alternative treatment for vision threatening blepharokeratoconjunctivitis: a case report","volume":"5","author":"Ismail","year":"2012","journal-title":"International Medical Case Reports Journal"},{"issue":"12","key":"10.1002\/14651858.CD011965.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2007.01.021","article-title":"Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis","volume":"114","author":"Jones","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"24","author":"Joseph","year":"2005","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Kacmaz","year":"2010","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00006454-199704000-00025","article-title":"History of macrolide use in pediatrics","volume":"16","author":"Klein","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archopht.1976.03910030459003","article-title":"Topical corticosteroid therapy and pituitary-adrenal function","volume":"94","author":"Krupin","year":"1976","journal-title":"Archives of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD011965.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes","volume":"118","author":"Kunert","year":"2000","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.exer.2005.08.019","article-title":"JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells","volume":"82","author":"Li","year":"2006","journal-title":"Experimental Eye Research"},{"issue":"11","key":"10.1002\/14651858.CD011965.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1167\/iovs.09-4992","article-title":"Suppressive effects of azithromycin on zymosan-induced production of proinflammatory mediators by human corneal epithelial cells","volume":"51","author":"Li","year":"2010","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD011965.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005556.pub2","article-title":"Interventions for chronic blepharitis","author":"Lindsley","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011965.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2006.00665.x","article-title":"Subconjunctival crystals in paediatric blepharokeratoconjunctivitis","volume":"84","author":"Mehta","year":"2006","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1067\/mpa.2000.110339","article-title":"Oral erythromycin treatment for childhood blepharokeratitis","volume":"4","author":"Meisler","year":"2000","journal-title":"Journal of AAPOS"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/jac\/dkn007","article-title":"Azithromycin alters macrophage phenotype","volume":"61","author":"Murphy","year":"2008","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD011965.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011750.pub2","article-title":"Systemic treatment for blepharokeratoconjunctivitis in children","author":"O'Gallagher","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011965.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","article-title":"Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction","volume":"25","author":"Perry","year":"2006","journal-title":"Cornea"},{"issue":"12","key":"10.1002\/14651858.CD011965.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/ICO.0b013e31823cc098","article-title":"A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction","volume":"31","author":"Prabhasawat","year":"2012","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0055|cit55","first-page":"1797","article-title":"Emerging treatment options for meibomian gland dysfunction","volume":"7","author":"Qiao","year":"2013","journal-title":"Clinical Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0891-5520(20)30481-5","article-title":"Blepharitis","volume":"6","author":"Raskin","year":"1992","journal-title":"Infectious Disease Clinics of North America"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11536960-000000000-00000","article-title":"Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods","volume":"9","author":"Ratcliffe","year":"2011","journal-title":"Applied Health Economics and Health Policy"},{"key":"10.1002\/14651858.CD011965.pub2-BIB0058|cit58","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD011965.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00003495-200161020-00003","article-title":"Comparative review of topical ophthalmic antibacterial preparations","volume":"61","author":"Robert","year":"2001","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/eye.2015.249","article-title":"Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome","volume":"30","author":"Rodr\u00edguez-Garcia","year":"2016","journal-title":"Eye"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","article-title":"Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis","volume":"22","author":"Rubin","year":"2006","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ajo.2007.06.028","article-title":"Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire","volume":"144","author":"Sacchetti","year":"2007","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011965.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1167\/iovs.10-5658","article-title":"Effect of topical azithromycin on corneal innate immune responses","volume":"52","author":"Sadrai","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Advances in Therapy"},{"issue":"6","key":"10.1002\/14651858.CD011965.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.72.6.448","article-title":"Conjunctival anaerobic and aerobic bacterial flora in paediatric versus adult subjects","volume":"72","author":"Singer","year":"1988","journal-title":"British Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011965.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","article-title":"New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome","volume":"114","author":"Sotozono","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3928\/0191-3913-20010501-13","article-title":"Adrenal suppression and growth retardation from ocular corticosteroids","volume":"38","author":"Steelman","year":"2001","journal-title":"Journal of Pediatric Ophthalmology and Strabismus"},{"issue":"5","key":"10.1002\/14651858.CD011965.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011965.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1167\/iovs.09-4596","article-title":"Tear osmolarity as a biomarker for dry eye disease severity","volume":"51","author":"Suzuki","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD011965.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jtos.2014.12.002","article-title":"Meibomian glands and ocular surface inflammation","volume":"13","author":"Suzuki","year":"2015","journal-title":"The Ocular Surface"},{"issue":"10","key":"10.1002\/14651858.CD011965.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bjo.2005.070888","article-title":"Topical ciclosporin in the treatment of ocular surface disorders","volume":"89","author":"Tatlipinar","year":"2005","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011965.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajo.2011.08.037","article-title":"Severity of pediatric blepharokeratoconjunctivitis in Asian eyes","volume":"153","author":"Teo","year":"2012","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1185\/03007995.2010.539603","article-title":"Evaluation of clinical efficacy and safety of tobramycin\/dexamethasone ophthalmic suspension 0.3%\/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis\/blepharoconjunctivitis","volume":"27","author":"Torkildsen","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD011965.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Medical Care"},{"issue":"4","key":"10.1002\/14651858.CD011965.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/bjo.2004.052134","article-title":"Blepharokeratoconjunctivitis in children: diagnosis and treatment","volume":"89","author":"Viswalingam","year":"2005","journal-title":"British Journal of Ophthalmology"},{"issue":"5-6","key":"10.1002\/14651858.CD011965.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1515\/jpem.2011.048","article-title":"Growth suppression caused by corticosteroid eye drops","volume":"24","author":"Wolthers","year":"2011","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD011965.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaapos.2009.11.021","article-title":"Managing a child with an external ocular disease","volume":"14","author":"Wong","year":"2010","journal-title":"Journal of AAPOS"},{"issue":"11","key":"10.1002\/14651858.CD011965.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011965","article-title":"Topical treatments for blepharokeratoconjunctivitis in children","author":"O'Gallagher","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011965.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T02:38:51Z","timestamp":1710902331000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011965.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011965.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]}}}